Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismail Khan

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Scientific Reports|December 1, 2021
Biallelic inheritance in a single Pakistani family with intellectual disability implicates new candidate gene RDH14Stephen F Pastore, Tahir Muhammad, Ricardo Harripaul, et al.
International Journal of Environmental Research and Public Health|December 11, 2012
Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in BangladeshMohammad Rafiqul Islam, Ismail Khan, John Attia, et al.
Circulation. Genomic and Precision Medicine|April 26, 2021
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart AssociationTochi M Okwuosa, Alicia Morgans, June-Wha Rhee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitorDenise A Yardley, Roohi R Ismail-Khan, Bohuslav Melichar, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Environmental Research|September 24, 2023
Rainwater harvesting for agriculture development using multi-influence factor and fuzzy overlay techniquesXiangtian Zheng, Abid Sarwar, Fakhrul Islam, et al.
Cardio-Oncology (London, England)|June 1, 2021
Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapyMichael G Fradley, Mohammed Alomar, Marcus W Kilpatrick, et al.
Current Oncology Reports|April 15, 2021
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program BuildingDiego Sadler, Anita Arnold, Joerg Herrmann, et al.
Clinical Breast Cancer|December 14, 2021
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)Julie A Means-Powell, Ingrid A Mayer, Roohi Ismail-Khan, et al.
Oncotarget|October 21, 2014
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsHatem H Soliman, Erica Jackson, Tony Neuger, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Scientific Reports|December 1, 2021
Biallelic inheritance in a single Pakistani family with intellectual disability implicates new candidate gene RDH14Stephen F Pastore, Tahir Muhammad, Ricardo Harripaul, et al.
International Journal of Environmental Research and Public Health|December 11, 2012
Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in BangladeshMohammad Rafiqul Islam, Ismail Khan, John Attia, et al.
Circulation. Genomic and Precision Medicine|April 26, 2021
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart AssociationTochi M Okwuosa, Alicia Morgans, June-Wha Rhee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitorDenise A Yardley, Roohi R Ismail-Khan, Bohuslav Melichar, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Environmental Research|September 24, 2023
Rainwater harvesting for agriculture development using multi-influence factor and fuzzy overlay techniquesXiangtian Zheng, Abid Sarwar, Fakhrul Islam, et al.
Cardio-Oncology (London, England)|June 1, 2021
Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapyMichael G Fradley, Mohammed Alomar, Marcus W Kilpatrick, et al.
Current Oncology Reports|April 15, 2021
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program BuildingDiego Sadler, Anita Arnold, Joerg Herrmann, et al.
Clinical Breast Cancer|December 14, 2021
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)Julie A Means-Powell, Ingrid A Mayer, Roohi Ismail-Khan, et al.
Oncotarget|October 21, 2014
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsHatem H Soliman, Erica Jackson, Tony Neuger, et al.
Pageof 14